Coverage
-
March 17, 2016
Massachusetts-based pharmaceutical company Braintree told a New York federal court Thursday that it intends to appeal a judge's Tuesday order that a rival company does not infringe its patent that covers the laxative drug Suprep.
1 other articles on this case.
View all »